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HYPOTHESES 
1. Obesity causes a reduction in lung volume and with this change in lung 
function predisposes obese subjects to an increase in diagnosis of 
asthma, bronchial hyperresponsiveness and symptoms of asthma 
including wheeze and shortness of breath. 
2. This increase in asthma prevalence occurs in both obese adults and 
obese children. 
3. Other factors that also cause a reduction in lung volume, such as lying 
supine will also increase bronchial hyperresponsiveness in both non-
asthmatics and asthmatics. 
4. Obesity primarily affects lung function through a direct mechanical 
effect on lung volumes. An alternative hypothesis exists that the effect 
of obesity on lung function is through associated conditions such as 
gastro oesophageal reflux or obstructive sleep apnoea, which are 
increased in the obese.  
5. Obese subjects with reduced lung volume will have a change in 
position of the high dose methacholine curve and plateau in the 
absence of asthma diagnosis or symptoms.  
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THESIS ABSTRACT 
Over the last 20 years both asthma and obesity have increased in prevalence. 
What is the link? There are data to suggest that increasing obesity is a risk for 
the increase in prevalence of asthma. A number of mechanisms have been 
postulated including the effects of reduced lung volume on bronchial reactivity 
and mechanical changes with lower lung volumes. Other possibilities include 
other obesity-induced co-morbidities including gastro-oesophageal reflux. 
The aim of this thesis was to evaluate the link between asthma and obesity in 
both adult and childhood populations and to undertake experimental studies 
to examine the effects of changes in lung volume on bronchial reactivity. 
In chapter 1, the literature is reviewed.  The current literature suggests that 
there is a link between diagnosis of asthma, new onset of asthma, symptoms 
of shortness of breath and wheeze.   
In chapter 2, data on 1997 adults in 3 population studies were analysed and 
the association between body mass index (BMI) and symptoms of shortness 
of breath and wheeze, diagnosis of asthma, medication usage for asthma, 
lung function and bronchial responsiveness were studied. This study showed 
that obesity was a risk for recent asthma (OR 2.04; 95%CI 1.02-3.76, 
p=0.048), symptoms of shortness of breath and wheeze (OR 2.6; 95%CI 1.46-
4.70, p=0.001), and medication usage for asthma (OR 2.53; 95%CI 1.36-4.70, 
p=0.003).  
There was a reduction in lung volume as measured by forced vital capacity 
(FVC), but there was no increase in bronchial hyperresponsiveness (BHR) 
(OR 0.87; 95% CI 0.35-2.21, p=0.78).  Thus although the symptoms of 
asthma are increased there were no increases in BHR, despite significantly 
reduced lung volumes. The increase the medication usage is unlikely to have 
normalised the BHR, as there were ongoing symptoms suggestive of asthma. 
In chapter 3, data on 5993 children in 7 population studies were analysed and 
the association between BMI percentile and symptoms of cough, wheeze, 
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diagnosis of asthma, medication usage for asthma, atopy, lung function and 
bronchial responsiveness was studied. 
After adjusting for atopy, sex, age, smoking and family history, BMI was a 
significant risk factor for wheeze ever (OR=1.06; 95%CI 1.01-1.10, p=0.008) 
and cough (OR=1.09; 95%CI 1.05-1.14, p=0.001) but not for recent asthma 
(OR=1.02; 95%CI 0.98-1.07 p=0.43), or bronchial hyperresponsiveness 
(OR=0.97; 95%CI 0.95-1.04 p=0.77).  In girls, a higher BMI was significantly 
associated with higher prevalence of atopy (χ2 trend 7.9, p=0.005), wheeze 
ever (χ2 trend 10.4, p=0.001), and cough (χ2 trend 12.3, p<0.001).  These 
were not significant in boys. 
With increasing BMI in children, there was no reduction in lung volume, no 
increase in airway obstruction and no increase in bronchial responsiveness.  
In chapter 4, the hypothesis that obesity per se is associated with bronchial 
responsiveness was tested. Six obese women without asthma were 
compared to 6 non-obese women without asthma with high dose 
methacholine challenges to assess the bronchial responsiveness.  
There was no increase in bronchial responsiveness, and no difference in the 
position or shape of the high dose methacholine curve despite the fact that 
these women had reduced lung volumes associated with their obesity. 
In chapter 5, the hypothesis whether reduced lung volume per se would cause 
a change in greater mechanical effect, ie more marked airway narrowing in 
both non-asthmatic and asthmatic subjects was tested. Lung volumes and 
methacholine challenges were undertaken in the supine and erect position on 
different days. As expected in normal subjects there was a small reduction in 
lung volume on lying down, this was associated with an increase in the 
measure of bronchial reactivity DRR. In contrast, in asthmatics, there was no 
acute fall in lung volume and there were variable changes in the index of 
reactivity suggesting non-homogeneity in the lung function abnormality.  This 
suggests changes in bronchial reactivity can occur without any relationship to 
lung volume change.  
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These negative results suggest that lung volume changes that may occur in 
obesity are unlikely contributors to the apparent increase in asthma 
symptoms. 
In chapter 6, the hypothesis that the supposed increase in asthma symptoms 
in the obese were due to the effects of gastro-oesophageal reflux were 
assessed in 147 obese subjects graded for gastro-oesophageal reflux severity 
using manometry and gastroscopy. This study showed that subjects with 
increased gastro-oesophageal reflux did not have subjective increases in 
asthma prevalence, obstructive sleep apnoea, or snoring however they had a 
clear worsening of gas transfer as measured by carbon monoxide transfer 
suggesting a greater level of parenchymal disease.  
The overall results are that there is an increase of diagnosis of asthma, 
increase in symptoms of asthma and medication usage for the treatment of 
asthma in the obese. Objectively despite reductions in lung volume, there is 
no increase in bronchial responsiveness in this group suggesting that these 
symptoms are not related to true asthma, but to alternative co-morbidities 
associated with obesity such as gastro-oesophageal reflux. Notably gastro-
oesophageal reflux was not associated with increased asthma prevalence or 
airway obstruction. However it was associated with reduced gas transfer 
suggesting parenchymal disease.  
This suggests that the increase in symptoms of wheeze and shortness of 
breath in the obese should not be attributed to asthma in the absence of 
variable airflow limitation that is reversible spontaneously or with treatment, or 
with an increase in the existing bronchial hyperresponsiveness (BHR) to a 
variety of stimuli.  
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KCO - Single breath diffusing capacity corrected for alveolar volume 
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